The effects of exenatide twice daily compared to insulin lispro added to basal insulin in Latin American patients with type 2 diabetes: A retrospective analysis of the 4B trial-Reference-Cited by-同舟云学术

The effects of exenatide twice daily compared to insulin lispro added to basal insulin in Latin American patients with type 2 diabetes: A retrospective analysis of the 4B trial

Published:2016-12 Issue: Volume:122 Page:38-45
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

de Lapertosa Silvia Beatriz Gorban,Frechtel Gustavo,Hardy Elise,Sauque-Reyna Leobardo

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference21 articles.

1. Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment;Leslie;Diabetologia,2016

2. Obesity trends in Latin America: transiting from under- to overweight;Uauy;J Nutr,2001

3. Diabetes in South and Central America: an update;Aschner;Diabetes Res Clin Pract,2014

4. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993–2006;Villalpando;Salud Publica Mex,2010

5. Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes;Diamant;Diabetes Care,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the steady-state concentration, duration of action, or molecular weight of GLP-1RA associated with cardiovascular and renal outcomes in type 2 diabetes?;European Journal of Internal Medicine;2023-03

2. Use of glucagon-like peptide-1 receptor agonists among individuals on basal insulin requiring treatment intensification;Diabetic Medicine;2018-03-24

3. Insulin and Other Hypoglycemic Drugs;Side Effects of Drugs Annual;2017